TCLHF(TCLHF)
TCLHF
$2.17—Stale · unknown old
OTC • Last print unknown ago
$2.17—Stale · unknown old
No analyst ratings available
No analyst price targets available for TCLHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $131.19B | $159.73B | $176.64B |
| Low | $121.51B | $135.70B | $156.19B |
| High | $139.23B | $180.71B | $194.25B |
| EBITDA Avg | $6.85B | $8.14B | $9.34B |
| Low | $6.15B | $7.26B | $8.29B |
| High | $7.45B | $8.89B | $10.23B |
| EBIT Avg | $5.46B | $6.67B | $7.76B |
| Low | $4.76B | $5.79B | $6.72B |
| High | $6.07B | $7.42B | $8.66B |
| Net Income Avg | $3.21B | $4.04B | $4.80B |
| Low | $2.73B | $3.43B | $4.08B |
| High | $3.62B | $4.56B | $5.42B |
| EPS Avg | $1.26 | $1.59 | $1.89 |
| Low | $1.07 | $1.35 | $1.60 |
| High | $1.43 | $1.80 | $2.13 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $48.96B | $48.96B | $48.96B | $48.96B | $66.86B |
| Low | $48.96B | $48.96B | $48.96B | $48.96B | $66.86B |
| High | $48.96B | $48.96B | $48.96B | $48.96B | $66.86B |
| EBITDA Avg | — | — | — | — | $2.74B |
| Low | — | — | — | — | $2.74B |
| High | — | — | — | — | $2.74B |
| EBIT Avg | — | — | — | — | $2.42B |
| Low | — | — | — | — | $2.42B |
| High | — | — | — | — | $2.42B |
| Net Income Avg | — | — | — | — | $1.50B |
| Low | — | — | — | — | $1.50B |
| High | — | — | — | — | $1.50B |
| EPS Avg | — | — | — | — | $0.59 |
| Low | — | — | — | — | $0.59 |
| High | — | — | — | — | $0.59 |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / 1 |